True Private Wealth Advisors Intellia Therapeutics, Inc. Transaction History

True Private Wealth Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 20, 2020	SELL	$9.44 - $15.58 $726 - $1,199	-77 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$10.43 - $17.67 $803 - $1,360	77 New	77 $1,000
Q3 2019 Oct 09, 2019	SELL	$13.07 - $18.51 $1,006 - $1,425	-77 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$13.88 - $18.41 $1,068 - $1,417	77 New	77 $1,000
Q4 2018 Jan 14, 2019	SELL	$11.39 - $27.13 $170,975 - $407,248	-15,011 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$25.78 - $32.6 $44,212 - $55,909	1,715 Added 12.9%	15,011 $0
Q2 2018 Jul 13, 2018	BUY	$20.02 - $30.79 $50,710 - $77,991	2,533 Added 23.53%	13,296 $363,000
Q1 2018 Apr 25, 2018	BUY	$19.43 - $34.95 $209,125 - $376,166	10,763 New	10,763 $226,000

326

88.8M

673K

865K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.37B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on True Private Wealth Advisors with notifications on news.